Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Malignant Paraganglionic Neoplasm

Known as: Malignant Paraganglioma, Paraganglion Neoplasm, Malignant, Malignant Tumor of the Paraganglion 
A paraganglioma that metastasizes to regional or distant anatomic sites. Extraadrenal paragangliomas have a higher tendency to metastasize, as… 
National Institutes of Health

Related topics

Related topics

9 relations
Autonomic nervous systemCDISC SEND Tumor Findings Results TerminologyClinical Data Interchange Standards Consortium TerminologyEndocrine system
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta‐analysis
Chemotherapy with cyclophosphamide, vincristine and dacarbazine (CVD) can be used for palliative treatment of malignant… 
Review
2014
Review
2014
131I‐MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta‐analysis
131I‐MIBG therapy can be used for palliative treatment of malignant paraganglioma and phaeochromocytoma. The main objective of… 
Review
2012
Review
2012
Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis
The main objective of this study was to perform a systematic review and meta-analysis on the risk of developing malignant… 
Highly Cited
2012
Highly Cited
2012
Head and neck paragangliomas: Report of 175 patients (1989–2010)
Attention of the otorhinolaryngologist needs to be drawn to the versatile aspects of head and neck paragangliomas (PGLs). 
Highly Cited
2009
Highly Cited
2009
The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.
CONTEXT Germline mutations in SDHx genes cause hereditary paraganglioma. OBJECTIVE The aim of the study was to assess the… 
Highly Cited
2009
Highly Cited
2009
Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma.
CONTEXT Paragangliomas are tumors that develop from extraadrenal chromaffin cells. Approximately 20% of paragangliomas are… 
Highly Cited
2009
Highly Cited
2009
Novel Strategy for a Cocktail 18F-Fluoride and 18F-FDG PET/CT Scan for Evaluation of Malignancy: Results of the Pilot-Phase Study
18F-FDG PET/CT is used for detecting cancer and monitoring cancer response to therapy. However, because of the variable rates of… 
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • figure 4
Review
2009
Review
2009
Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).
Phaeochromocytoma and paraganglioma are rare neuroendocrine tumours (NETS). They may be benign or malignant but the pathological… 
Highly Cited
2006
Highly Cited
2006
High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing.
CONTEXT Adrenal and extraadrenal paragangliomas are tumors of chromaffin cells that are usually benign but that may also develop… 
Highly Cited
1995
Highly Cited
1995
Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma.
METHODS The results of in vivo somatostatin scintigraphy were correlated with those of MIBG from 14 patients, aged 22-66 yr, with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE